Bowel Cancer Foundation Trust Research Programmes

We partner with a number of leading clinicians, institutions and academics across New Zealand to help with research in to:

  •  Earlier screening of patients

  •  Help develop new and more effective treatments for bowel cancer

  •  Ensure patients get rehabilitated in the most effective way

 

improving outcomes to all bowel cancer patients across the country.

Through strategic investment in targeted research, we will help deliver improvements in bowel cancer survival throughout the years.

If you would like to donate specifically to fund research projects either via a bequest or grant please contact our CEO here.

If you are an academic and would like to put forward a research project for funding consideration, send through your details here.

Our current research programmes

K9MD Levi.jpg

Kiwi Medical Detection Dogs to be trialled in bowel cancer study

Levi - the 20 month old German Shepherd helping to detect bowel cancer and save lives

A New Zealand cancer screening trial, using specifically trained dogs to identify bowel cancer in urine, could help to save lives through early detection. The charities own trial is being sponsored by the Lindsay Foundation and will be undertaken by the K9 Medical Detection NZ Charitable Trust and Otago University between January 2020 and January 2022. The study will commence using ‘Levi’ - an adult German Shepherd who has received basic training in readiness for medical scent detection work. 

To read more click here...

The Colin McGill bowel cancer research programmes

L-R: Gwen Green, National Medical Lead of the NZ Familial Gastrointestinal Service Associate Professor Susan Parry, and Georgina Mason

Bowel Cancer Foundation Trust announced they are collaborating with Auckland Health Foundation on two significant pieces of bowel cancer research. The first piece of research is around familial bowel cancer. It seeks to define an individual’s bowel cancer risk by looking at their family history of the disease, determining if they carry an inherited gene mutation that increases their risk, and therefore improving treatment strategies and outcomes.

                                                To read more click here...

L-R: Gwen Green, Auckland DHB Allied Health Service Clinical Director Joe Monkhouse, and Georgina Mason

The Second piece of research is around bowel cancer rehabilitation, or more specifically “prehabilitation. ” The introduction of prehabilitation could provide insight into a patient’s post-operative rehabilitation needs, which may lead to a faster recovery time. Further benefits could include reducing post-operative complications, and increasing a patient’s motivation and engagement in post-op rehabilitation, therefore improving their quality of life.

                                                To read more click here...

CC number:

CC49309

  • Facebook App Icon
  • LinkedIn App Icon
580b57fcd9996e24bc43c521.png